Senti Biosciences Holdings shareholders approve merger at annual meeting
SNTI•Senti Biosciences Holdings stockholders approved the merger agreement with ST NewCo at the reconvened annual meeting on October 15, 2026. They also approved a reverse stock split ranging from 1-for-20 to 1-for-50, subject to board discretion.
1. Merger approved
Stockholders approved the merger agreement with ST NewCo at the reconvened annual meeting on October 15, 2026, and authorized common stock issuance upon exchange of Senti Holdings’ Senior Secured Convertible Notes.
2. Other meeting votes
Stockholders approved a reverse stock split ranging from 1-for-20 to 1-for-50, subject to board discretion, including authority to abandon it. They elected Timothy Lu, Edward Mathers and Frances D. Schulz and ratified KPMG as independent auditor for fiscal 2026. The adjournment proposal was not presented because the merger agreement had secured the required votes.
